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Received August 6, 2013; accepted October 28, 2013AbstractBackground: The effectiveness of microvascular decompression (MVD) has made trigeminal neuralgia (TN), hemifacial spasm (HFS), glos-
sopharyngeal neuralgia, and other cranial nerve rhizopathy diseases treatable by surgery. To ensure hearing preservation and surgical success, we
have presented our experience in the application of brainstem auditory evoked potential (BAEP) monitoring and neuro-endoscopy during MVD.
Methods: From July 2007 to October 2012, a total of 93 patients in our institution received MVD for cranial nerve rhizopathies. Among these
patients, 43 had both BAEP monitoring and endoscope-assisted microsurgery for their MVD. None of the patients had undergone previous
surgical treatment. Postoperative outcomes were assessed based on the medical records and clinical follow-up.
Results: This study included 32 women and 11 men. There were 36 HFS cases and seven TN cases, and the median patient age at the time of
MVD was 48 years. The median duration of symptoms before MVD was 4.2 years, and the median follow-up duration was 3.5 years (range 1.5
monthse5 years). All of the patients had either immediate or delayed complete relief from the symptoms after MVD. One TN patient underwent
gamma knife radiosurgery 3 years after MVD, and two HFS cases had recurrent slight spasms, which warranted no further treatment. There was
no surgical mortality. The major complications included one HFS patient with delayed and permanent hearing loss and facial palsy, which
occurred 1 week after MVD. The surgical success rate was 100%, and the hearing complication rate was 2%.
Conclusion: The results of this retrospective study emphasized the importance of BAEP monitoring and neuro-endoscopy during MVD. It is well
known that BAEP monitoring can preserve hearing function, and the endoscope offers neurosurgeons a second look to identify the nerve root
entry zone and confirms the position of the Teflon felt. These two tools are especially useful in difficult cases.
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Microvascular decompression (MVD) has become a mature
surgical technique in the management of trigeminal neuralgia
(TN), hemifacial spasm (HFS), glossopharyngeal neuralgia,
and other cranial nerve rhizopathies. The use of MVD to cure
cranial nerve rhizopathies is an effective procedure associated
with a low rate of complications and rare reports of operativeociation. All rights reserved.
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are either treatable or self-limiting. Although relatively un-
common, postoperative hearing loss is one complication that
can lead to permanent deficits. Deafness is thought to result
from excessive retraction or manipulation of the cranial nerve
(CN) VIII. In Jannetta’s experience,1e3 the rates of post-MVD
hearing complications were 2.6% in patients with HFS and 1%
in patients with TN. The cerebellar injury rate was 0.68%. In
our institute, the rate of complete relief from HFS after MVD
reached 98.4%; just 2.2% of the patients suffered from post-
operative hearing impairment, either transient or permanent,
and the rate of cerebellar complications was 0.6%.4 Additional
technical steps were undertaken to deal with difficult cases.5 In
recent years, we have used two important tools in our MVD
procedures: brainstem auditory evoked potential (BAEP)
monitoring and endoscopy. In this study, we share our expe-
rience with MVD and efforts taken to avoid hearing compli-
cations and improve surgical safety.
2. Methods2.1. Data collection and analysisTable 1




Site Bilateral ear insert transducers
Clicks Alternating compression and rarefaction
Intensity 80 dB SL
Duration 200 ms
Rate 11.33 Hz
Contralateral masking Broad-band white noise from 20 Hz to 20 kHz,
50 dB SL, wideband pseudorandom noise,
35 dB HL
Recording
Montagea Cz-A1 (left) and Cz-A2 (right), ground:
FpZ (midforehead)
Electrodes Subdermal needle electrode, 12 mm long/27
gauge in diameter
Impedance <2 kU
Filters 100 Hz to 3000 Hz
Sensitivity <25 mV
Sweep time 10 ms
dB HL ¼ decibels greater than average hearing level for normal population;
dB SL ¼ decibels greater than patient’s sensation level.
a Electrode positions as designated by the International Federation 10e20
electrode system.A retrospective chart review was conducted to identify
patients who had undergone first-time MVD for cranial nerve
rhizopathy by our two surgeons (Y.S.Y. and C.F.L.) in Taipei
Veterans General Hospital, Taipei, Taiwan, R.O.C., between
July 2007 and October 2012. Hospital charts and clinical re-
cords were carefully reviewed, and clinical data including
demographic information, preoperative history, physical find-
ings, postoperative results, and complications were entered
into the database, which was agreed by all the enrolled
patients.
All patients received magnetic resonance imaging (MRI) of
the brain [including a series of fast imaging employing steady
state acquisition (FIESTA) and angiography] to exclude mass
lesions and to evaluate possible nerveevessel conflicts. The
visual analogue scale (VAS) was used for pain assessment, and
the HouseeBrackmann grading system was used for facial
palsy. Pre-operative preparation also included recordings of
facial motor evoked potential (MEP)/electromyography
(EMG), brainstem auditory evoked potential (BAEP), and pure
tone audiometry (PTA).
Outcomes were divided into four categories: immediate
complete relief, delayed complete relief, failure, and recur-
rence. Immediate complete relief was defined as the resolution
of spasms/neuralgia within 24 hours after the operation, and
delayed complete relief was defined as the resolution of
spasms/neuralgia not within 24 hours after the operation but in
the later clinical follow-up. Failure was defined as anything
other than complete relief; recurrence was defined as spasms/
neuralgia recurring after a period of complete relief. There was
no “partial relief” category for patients with residual spasms
who exhibited some improvement, which avoided subjectivity.
For the assessment of postoperative hearing impairment,
PTA was checked 1 month after operation in 35 patients
(81.4%). The appropriate BAEP tests were performed onpatients with objective hearing deficits in postoperative as-
sessments in order to differentiate the origin of hearing
impairment. Hearing was considered normal if the patient re-
ported no subjective deficit when questioned, and if it was
grossly intact during clinical assessment. The postoperative
facial nerve function or neuralgia was assessed according to the
nature of the patient’s presentation in the outpatient department.2.2. Intra-operative monitoring: BAEPThe main objective of intra-operative neuromonitoring
during MVD is to prevent injury to the nervous system. It is
particularly important to preserve the patient’s sense of hear-
ing because cranial nerve (CN) VIII is at risk during several
steps of the surgical procedure. Therefore, we focus on BAEP
monitoring here.
After the patient was anesthetized, the needle electrodes
(Spes Medica, MN35P150) were inserted in the earlobe (A1
and A2) and on the vertex (Cz) for BAEP recordings. The
auditory stimulus consisted of rarefaction negative clicks
delivered through disposable foam ear tips connected to an
electricalemechanical transducer by two plastic tubes, one for
each ear (Insert Earphone Kit: 359020-000; Foam Ear Tip:
Adult (50/pack): 202710-000; Cadwell Laboratories,
Kennewick, WA, USA). The auditory stimulator had to be
secured in the external auditory canal, which was sealed for
waterproofing. Constant 80-dB click sound stimulation was
delivered to the affected side, and 80-dB masking sounds to
the contralateral side. The impedance of each electrode was
maintained under 2 kU. The input signals were amplified and
averaged by the signal processor (Cascade; Cadwell Labora-
tories, Kennewick, WA, USA). The detailed parameters are
listed in Table 1.
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crease in wave V absolute latency is usually the most common
and earliest sign of dysfunction seen with stretching that oc-
curs during cerebellar retraction.6 We defined the “red flag” as
a wave IeV interpeak latency (IPL) >1 ms compared to that
of the baseline and a decrease in wave V amplitude >50%.
Once a “red flag” was noticed, a warning call to stop was
delivered to the neurosurgeon. If a thermal or traction injury
was suspected, the neurosurgeon temporarily removed the
retractor and paused the surgery until the BAEP recordings
improved.
The BAEP waveforms are relatively unaffected by anes-
thetics. However, body temperature, significant blood loss/
anemia, and blood pressure have more significant effects on
BAEP waveforms. The latency of wave V increases 0.2 ms for
every 1C drop in temperature.7 Hence, we preferred to keep
the body temperature above 36C to get better BAEP quality.
The baseline recordings were collected at the beginning of the
operation and compared with that of the preoperative auditory
brainstem response. We maintained monitoring throughout the
operation until wound closure. Prior to the durotomy, the time
interval between each recording was 10 minutes; after dur-
otomy, each recording was performed at 3-minute intervals.
BAEP recordings can be affected by surgical maneuvers.
For example, electrocautery and drilling cause artifacts. The
recording can be temporarily discontinued during drilling, but
it is necessary to carefully assess the waveforms prior to andFig. 1. Comparison of the microscopic and endoscopic views during MVD for right
(CN7/8) and adjacent vessels (right petrosal vein and right SCA). The facial nerve a
(C) After dissection around the trigeminal nerve, the endoscope offered a clear vi
endoscopy, the indentation of the trigeminal nerve caused by the SCA was c
MVD ¼ microvascular decompression; REZ ¼ root entry zone; SCA ¼ superiorafter drilling to detect a rare complication of the vasospasm
that results in ischemia of the cochlea.8 The durotomy and the
cerebrospinal fluid (CSF) drainage may cause loss of wave II
and a decrease in the amplitude of wave III and/or wave V. In
our experience, once the durotomy was completed, a second
baseline waveform was documented and recorded for suc-
cessive comparisons. Of note, wide arachnoid dissection
around CNVIII should be done as soon as possible after the
durotomy. Otherwise, further surgical maneuvers will cause
BAEP waveform changes.2.3. Endoscope-assisted microsurgeryThe surgical procedures used here were based on the
techniques modified by Huang et al4 and Jannetta et al.1,2 The
anesthetic and monitoring equipment was placed at the end of
the operating table. The patient was placed in the supine-
lateral position. The head, which was secured with three-
point fixation, was rotated slightly away from the affected
side and flexed to approximately two finger breadths from the
sternum. The vertex of the head was kept parallel to the floor
in a trigeminal nerve approach or dropped 15 toward the floor
in a seventh or lower cranial nerve approach. The external
landmarks, including the mastoid eminence, digastric groove,
and inion, were used to define the junction of the transverse
and sigmoid sinuses. A vertical incision, about 8 cm long, was
made 0.5 cm posterior (medial) and parallel to the hair line.side TN. (A) The microscopic view of the CN 5 and vestibulocochlear complex
nd its REZ were obscured. (B) The endoscope offered an overview of the CPA.
ew of the relationship between the trigeminal nerve and the SCA. (D) Under
learly demonstrated. CN ¼ cranial nerve; CPA ¼ cerebellopontine angle;
cerebellar artery; TN ¼ trigeminal neuralgia.
Fig. 2. Comparison of the microscopic and endoscopic views prior to and after Teflon placement during MVD for the left side HFS. In this case, the REZ of the left
facial nerve was deeply located and difficult to evaluate with the microscope (A). With the aid of the endoscope (B), we could ensure the precise location of the
REZ and confirm the position of the Teflon felt (C and D). HFS ¼ hemifacial spasm; MVD ¼ microvascular decompression; REZ ¼ root entry zone.
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junction of the transverse and sigmoid sinuses, and one-
quarter above. After periosteal dissection, the burr hole was
placed at the region above the mastoid emissary vein, supero-
medial to the digastric groove, using a perforator. We placed
the lower edge of the junction of the transverse and sigmoid
sinuses at the superior and anterior margin of a small retro-
sigmoid craniectomy, the size and shape of which was tailored
according to the desired cranial nerve approach. Either a
curvilinear or T-shaped incision was made in the dura mater.
Exposing the most superior and lateral corner of the dura
adjacent to the junction of the transverse and sigmoid sinuses
was essential. Using the operative microscope, a pinpoint and
extensive arachnoid dissection was performed to fenestrate the
lateral cisterns, down to the cisterna magna, to drain the CSF
and relax the cerebellum. A self-retaining retractor was
introduced to elevate the supero-lateral margin of the cere-
bellum with its distal end immediately above the floccu-
lonodular lobe. Excessive retraction was avoided in order to
preserve cranial nerve functions and prevent the avulsion of
the petrosal vein complex. After generous arachnoid dissec-
tion, the retractor was then advanced further until its tip was
adjacent to where the choroid plexus extends laterally from the
fourth ventricle. We dissected the arachnoid membranes
around the vestibulocochlear complex and adjacent vessels,
especially the anterior inferior cerebellar artery (AICA) andthe posterior inferior cerebellar artery (PICA), and then visu-
alized the facial nerve and its root entry zone (REZ), which is
the most important step of MVD for the treatment of HFS. The
trigeminal nerve is located much deeper in the surgical field,
and injury to the CNVIII should be avoided during the
arachnoid dissection around the trigeminal nerve and sur-
rounding vessels (Fig. 1). Frequent visualization of the
retractor is paramount because it has a tendency to slip.
After the arachnoid dissection, the rigid endoscope was
introduced. The diameter of the endoscope was 3.0 mm, with
an angulation of 0, 30, or 45 (Karl Storz, Tuttlingen, Ger-
many). The endoscope, held by the free hand, was used to
recheck the actual vesselenerve conflicts around the REZ of
the affected nerves (Fig. 2). Teflon felt was placed under the
microscope, and its position was confirmed under endoscopy.
The BAEP changes during this part of the procedure were
frequent due to the traction on the CNVIII. If BAEP changes
occurred, the retractor was relaxed, and the surgeon paused
and waited for the return of the BAEP waveforms (Fig. 3). The
amount of Teflon felt should be appropriate, and not exces-
sively bulky. Sometimes repositioning is necessary (Fig. 4 and
Video 1). After the placement of the Teflon felt, we watched
for any changes in the BAEP waveforms for 15 minutes. If the
monitoring results remained constant, the wound was closed.
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.jcma.2014.02.016.
Fig. 3. BAEP monitoring during MVD for the right side TN. The baseline BAEP waveforms are at the top. During the procedure, a prolongation of wave IeV >
1 ms compared to that of baseline, and a decrease of wave V amplitude (VeVa) > 50% occurred. These changes were suspected to be due to the cerebellar
retraction. Therefore, we removed the retractor, paused the operation, and irrigated with warm normal saline. The BAEP waveforms gradually recovered. The
position of the Teflon sponge was finally checked under the endoscope, and the wound was closed. The patient had no hearing deficits after the operation.
BAEP ¼ brainstem auditory evoked potential; MVD ¼ microvascular decompression; TN ¼ trigeminal neuralgia.
312 C.-C. Lee et al. / Journal of the Chinese Medical Association 77 (2014) 308e3163. Results3.1. Patient characteristics and operative findingsA thorough search of hospital and clinical records produced a
total of 93 patients that received MVD for cranial nerve rhizo-
pathies in Taipei Veterans General Hospital from July 2007 to
October 2012. Of these patients, 43 (32 women and 11men) had
undergone BAEP monitoring and endoscope-assisted micro-
surgery for their MVD. There were 36 HFS cases and seven TN
cases. The median duration of symptoms prior to MVD was
4.2 years. Some patients had previous treatments, such as an-
algesics, sedatives, anticonvulsants, or botulinum injections, but
none had undergone prior surgical intervention. Additionally,
none of the patients suffered either HFS or TN due to tumors,
arteriovenous malformations, or aneurysms. Table 2 provides a
summary of patient characteristics, including the vascular
anatomy in relation to the REZ, which was documented by the
operating surgeon at the time of surgery.3.2. Outcome of BAEP-monitored and endoscope-
assisted MVDThirty-eight of the 43 patients had at least 1 year of post-
operative follow-up, and the median follow-up duration was3.5 years (range 1.5 monthse5 years) for all patients. There was
no surgical mortality in this study. All of the patients had either
immediate or delayed complete relief of the symptoms after
MVD. The recurrence rate was 7%: one TN case underwent
gamma knife radiosurgery 3 years after MVD, and two HFS
cases had recurrent slight spasms, which did not warrant reop-
eration (Table 3). The illustrated case is shown in Fig. 4.
Compared to the other 50 patients, the success rate was
higher (100% vs. 92%) when BAEP and endoscopy were used
during surgery.3.3. Complications of BAEP-monitored and endoscope-
assisted MVDTable 3 presents a summary of operative complications in
all 43 patients. No surgical mortality, brainstem infarctions,
cerebellar injury, or complications that required further oper-
ative intervention occurred. The major complications included
a HFS case of delayed and permanent hearing loss and facial
palsy 1 week after MVD. There were three HFS cases with
postoperative transient facial palsy, one immediate and two
delayed. Hearing complications occurred in two patients,
where one was transient and the other permanent. The patient
with transient hearing loss had a conduction loss after opera-
tion (proved by PTA), and further exams including BAEP and
Fig. 4. The changes in BAEP waveforms during MVD for the left side HFS. The operative video is illustrated in Video 1. During Teflon placement, a prolongation
of wave IeV IPL did not exceed more than 1 ms compared to that of baseline, but a decrease in wave Vamplitude (VeVa) > 50% occurred. We suspected that the
BAEP changes were due to the oversized Teflon felt. Therefore, we removed it. The operation was paused for 30 minutes to wait for the recovery of the BAEP
waveforms. After the recovery, an adequate sized of Teflon felt was placed again. No red flags on the BAEP waveforms were noticed up to and including the wound
closure. The patient had immediate complete relief of the symptoms after the operation, and there were no hearing deficits. BAEP ¼ brainstem auditory evoked
potential; HFS ¼ hemifacial spasm; IPL ¼ interpeak latency; MVD ¼ microvascular decompression.
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some fluid retention in the middle ear cavity. Six months later,
the hearing improved gradually when the fluid was eliminated.
BAEP wave changes in these two patients with hearing loss
were significant: wave IeV IPL were prolonged more
(5.71 ms vs. 5.07 ms) and wave V amplitudes were greatly
decreased (0.32 mV vs. 0.21 mV; Table 4). The most significant
differences usually occurred during the period when surgeons
placed the Teflon until they began to close the wound (Table
4). Although the wave IeV IPLs and wave V amplitudes in
these two patients seemed to have recovered gradually prior to
the end of surgeries, they were slower in their recoveries than
those patients who had no postoperative hearing loss (Table 4).
By contrast, compared to the other 50 patients who un-
derwent MVD without BAEP and endoscopy, both the inter-
mediate and permanent hearing preservation rates were higher
(98% vs. 88% and 98% vs. 96%, respectively) when BAEP
and endoscopy were used during surgery.4. Discussion4.1. The benefits of endoscope-assisted MVDWith the aid of the surgical microscope, Jannetta9 refined and
popularizedMVD as a treatment for TNmore than 40 years ago.
After years of practice, he demonstrated that MVD served as an
extremely safe and effective treatment for TN, HFS, glosso-
pharyngeal neuralgia, and other cranial nerve rhizopathies in
appropriately selected patients.1,3 However, some inherent
limitations of this microsurgical technique still exist. The major
difficulty of this procedure is clearly identifying the relationship
between the REZ and the offending vessels under the micro-
scope. The candidate cranial nerve arises from the bulbopontine
groove of the brainstem, just behind the cerebellum and hidden
from the view of a retrosigmoid approach. Cerebellar retraction
is always warranted, and this becomes the main source of
postoperative complications. The complex anatomy of the
Table 2
Summary of demographic and clinical characteristics.
Variable Value (n) or
percentage (%)
Case number (n) 43
Follow-up >1 year (n) 38
Follow-up <1 year (n) 5
Diagnosis (HFS:TN) 36:7
Median age at MVD (y) 48
Sex (female:male) 32:11
Laterality (right:left) 21:22
Median duration of symptoms before MVD (y) 4.2
Medication use before MVD in TN patients (%) 100
Local treatment before MVD in TN patients (%)* 86
Botox therapy before MVD in HFS patients (%) 64
Median follow-up duration (y) 3.5
Offending vessel
SCA** 4 (9.3)
SCA þ AICA** 1 (2.3)
SCA þ vein** 2 (4.6)
AICA 3 (7.0)
AICA þ PICA 1 (2.3)
PICA 14 (32.6)
PICA þ VA 2 (4.6)
PICA þ vein 2 (4.6)
VA 7 (16.3)
Unnamed small artery 7 (16.3)
AICA ¼ anterior inferior cerebellar artery; Botox ¼ botulinum toxin; PICA ¼
posterior inferior cerebellar artery; SCA ¼ superior cerebellar artery; VA ¼
vertebral artery.
* TN treatment including radiofrequency thermorhizotomy, balloon
compression, glycerol or alcohol injection.
** All of the offending vessels in these three categories belonged to the seven
patients with TN.
Table 3
Outcomes and complications of BAEP-monitored/endoscope-assisted MVD.
Outcomes No. of patients (%)
Immediate complete relief 27 (62.8)






















* One TN case had recurrence and underwent gamma knife radiosurgery 3
years after MVD, with subsequent facial hypoesthesia. Two HFS cases had
recurrent slight spasms, which warranted no reoperations.
** One HFS case had both delayed hearing loss and facial palsy, House-
Brackmann grade III, postoperatively.
*** Three HFS cases had transient facial palsy, House-Brackmann grade II.
One was immediate, and the rest were delayed facial palsy. The weakness of
the three patients had completely resolved by the latest follow-ups.
Table 4
Latencies (mean  SD) for wave IeV IPL and wave Vamplitude at successive
stages during the MVD procedure.
Operative stage Wave IeV IPL (ms) Wave V amplitude (mV)
Group 1 Group 2 Group 1 Group 2
Anesthesia
induction
4.30  0.36 4.24  1.13 0.62  0.10 0.65  0.50
Incision 4.25  0.43 4.10  1.25 0.61  0.13 0.63  0.52
Craniotomy 4.29  0.45 4.12  1.20 0.62  0.13 0.64  0.54
Dura opening 4.57  0.50 4.68  1.32 0.46  0.09 0.44  0.27
Retractor on 4.90  0.56 5.27  1.86 0.47  0.08 0.40  0.20
Teflon placement 5.07  0.57 5.71  1.91* 0.41  0.10 0.36  0.25*
314 C.-C. Lee et al. / Journal of the Chinese Medical Association 77 (2014) 308e316posterior fossa and the limited working space make adequate
visualization of the nerveevessel conflicts difficult when using
an operating microscope. In this situation, the endoscope fa-
cilitates the operation by offering accurate visualization of all
nerveevessel conflicts and confirming complete decom-
pression.8,10e12 In our study, the microscope offers three-
dimensional information of the operative field, while the
endoscope provides the ability to look behind structures and
around corners. The combination of the two devices improves
surgical safety and efficiency. Although there are some reports
on fully endoscopic vascular decompression for cranial nerve
rhizopathies,8,13e15 we do not suggest a pure endoscopic
vascular decompression because the two-dimensional infor-
mation that the endoscope provides lacks a sense of depth.
Under the operating microscope, exact arachnoid dissection can
be carried out around critical neurovascular structures, which
always precedes the application of the endoscope. In our
experience, the routine use of the endoscope did not lengthen the
operative time but facilitated the whole process. Additionally,
the success rate of complete relief was 100% in the current
study, with no complications resulting from brainstem injury.Retractor off 5.03  0.58 5.89  1.88* 0.41  0.09 0.33  0.27*
Closure 4.78  0.48 5.12  1.89* 0.58  0.11 0.35  0.21*4.2. The benefits of BAEP-monitored MVD
Group 1 ¼ no hearing loss; Group 2 ¼ hearing loss (including transient one
and temporary one).
IPL ¼ interpeak latency; MVD ¼ microvascular decompression;
SD ¼ standard deviation.
*p < 0.05.MVD is an effective treatment for HFS and TN, but the
procedure is associated with a significant risk of complications
such as hearing loss. In the literature, the rates of hearing lossafter first-time MVD ranged from 1.3% to 5.8%.2,4,16e20 The
complication is possibly due to the stretching of CNVIII,
labyrinthine artery manipulation, direct trauma with in-
struments, a nearby coagulation, or neocompression of the
cochlear nerve by the prosthesis. BAEP monitoring is the best
way to avoid postoperative hearing deficits.2,4,16,21,22 Although
no consensus exists among neuromonitorists about what
changes in waveforms are the most useful predictors,23e26
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decreased the incidence of post-MVD hearing impair-
ment.3,4,22,23 Our results also indicated that fewer instances of
patient immediate and permanent hearing loss occurred when
using BAEP monitoring during MVD. In rare circumstances,
hearing may still be perceived in patients with a complete loss
of BAEP waveforms; delayed hearing impairment was also
observed in a few patients who had normal BAEP waveforms
during MVD.17,19,25,27 Nevertheless, BAEP monitoring re-
mains the most sensitive test for hearing evaluation in anes-
thetized patients. In our study, we defined the index changes
(red flags) of BAEP waveforms as (1) wave IeV IPL >1 ms
compared to that of baseline, and (2) the decrease of wave V
amplitude >50%. These two red flag signs were relatively
easy for intraoperative interpretation and communication be-
tween neuromonitorists.
BAEP is also an indicator for surgical manipulations of the
brainstem. Changes in wave IeIII IPL indicate that the lower
brainstem structures at the level of the auditory nerve or the
cochlear nucleus are affected (on the stimulated side). From
wave III to V, the sensory input of the stimulated side ascends
via secondary auditory pathways, most of them crossing
contralaterally at several levels within the pons through the
lateral lemniscus (contralateral fibers > ipsilateral fibers).6
Hence, contralateral changes in wave IIIeV IPL indicate
that surgical manipulations have an effect on the brainstem.
These changes in BAEP waveforms occur earlier than the
fluctuations of the heart rate and blood pressure,28 which
serves as a better indicator for brainstem manipulations than
the traditional cardiovascular parameters.4.3. Debate on monitoringDannenbaum et al18 reported the results of 114 consecutive
patients who underwent MVD for HFS without the use of
neurophysiological monitoring. A KaplaneMeier analysis
showed that 86% of the patients were spasm-free 10 years post-
operatively. There was one case of postoperative deafness, one
case of permanent subtotal hearing loss, and 10 cases of delayed
facial palsy, two of which did not completely resolve. They
concluded that MVDwithout neurophysiological monitoring is a
safe and effective treatment option for patients with HFS. How-
ever, Samii et al19 reported that deafness was the main post-
operative complication (8.3%). Most of those cases (66%)
occurred prior to the routine use of BAEP monitoring during
MVD forHFS.Moller andMoller24 reported that the incidence of
postoperative hearing deficits decreased from6% to 10% to 2.8%
after the routine use of BAEPmonitoring; Radtke et al22 reported
a decrease from 6.6% to 0%. McLaughlin et al’s review3 of the
Pittsburgh experiencewithMVDcreditedBAEPmonitoringwith
the decrease in hearing complications (from 1.98% to 0.80%).
Although there is no consensus or guideline that suggests the
types of BAEP changes that are the most useful predictors and
thus appropriate for clinical use,23e26 BAEP monitoring has
becomea routine part ofMVDsurgeries atmany large centers due
to its salient benefits. More data are needed to refine a widely
acceptable guideline for BAEP monitoring in the future.4.4. Complications and limitations of our studyIn our study, the one HFS patient with delayed and permanent
hearing loss and facial palsy (HouseeBrackmann grade III)
1 week after MVD had a dolichoectatic vertebral artery, which
probably posed a slightly higher risk of cranial nervemorbidity.29
In addition to Teflon felt, we also used a sling technique to lift the
offending vertebral artery.5 During the surgical procedure, the
wave IeV IPL was prolonged and the wave V amplitude was
decreased; however, neither reached the warning sign level as
defined above. Nonetheless, delayed hearing loss occurred
1 week after MVD. We suspected the cause of this loss to be
hemodynamic changes due to the overt sling technique,which led
to delayed ischemia and resultant complications. Another
explanation was ischemia secondary to vasospasm after the sur-
gical manipulation. It is also important to avoid excessive
angulation of the offending vessel in the sling technique, which
might decrease the rate of delayed complications.
The limitations of our study were the retrospective design,
small patient numbers, and grouped outcomes (HFS and TN).
Inevitably, the surgical techniques by different neurosurgeons
also resulted in some bias that affected the outcome. Even
though the MVD procedure has been standardized over the
years, the actual technique can vary greatly between doctors,
which in turn could affect the treatment outcome.
In conclusion, MVD is a standardized surgical procedure for
the treatment of TN, HFS, glossopharyngeal neuralgia, and
other cranial nerve rhizopathies, frequently resulting in excel-
lent outcomes. This retrospective study emphasized the impor-
tance of both BAEP monitoring and neuro-endoscopy during
MVD. Essentially, BAEP monitoring confirms hearing preser-
vation while the endoscope offers neurosurgeons a second look
to identify the REZ, and to ensure the position of the Teflon
sponge. These two tools are especially useful in difficult cases.References
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